In a study of adults older than in the present study, levels of cerebrospinal fluid glial fibrillary acidic protein—a marker of microglia activity and neuroinflammation in the brain—were higher in older men with chronic pain compared to those without chronic pain, but those with chronic pain were not more likely to show amyloidosis (5). Here, GFAP is linked to amyloidosis.